ESC Premium Access

8-hydroxy-2-deoxyguanosine predicts microvascular obstruction after primary percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction.

Topic: Infarction acute phase STEMI

Congress Session

About the speaker

Mr Yugo Minamimoto

Yokohama City University Medical Center, Yokohama (Japan)
0 follower

70 more presentations in this session

Acquired thrombocytopenia after transcatheter aortic valve implantation (TAVI): association with clinical outcome

Speaker: Doctor C. Espada Guerreiro (Vila Nova de Gaia, PT)

Thumbnail

Ventricular conduction blocks: prevalence, temporal evolution, and impact on survival in cardiogenic shock

Speaker: Doctor H. Tolppanen (Helsinki, FI)

Thumbnail

Pre-hospital and in-hospital mortality from myocardial infarction in Berlin

Speaker: Assistant Professor M. Stockburger (Nauen, DE)

Thumbnail

Development of antithrombotic therapy and bleeding complications in patients with ACS over time: Data from a local myocardial infarction registry

Speaker: Doctor J. Roehnisch (Berlin, DE)

Thumbnail

The impact of delay from diagnostic ECG to wire on infarct size, myocardial salvage and clinical outcome in STEMI patients treated with primary percutaneous coronary intervention

Speaker: Doctor L. Nepper-Christensen (Copenhagen, DK)

Thumbnail

Access the full session

Poster session 6 - Latest on STEMI

Speakers: Mr Y. Minamimoto, Doctor C. Espada Guerreiro, Doctor H. Tolppanen, Assistant Professor M. Stockburger, Doctor J. Roehnisch...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk